MedPath

Study of efficacy of Nishadi Ghana Vati and Karanja tail local application in skin disease

Phase 2
Not yet recruiting
Conditions
Atopic dermatitis, unspecified,
Registration Number
CTRI/2021/01/030491
Lead Sponsor
Manisa Singh
Brief Summary

This study is Randomized, controlled clinical study of Nishadi Ghana Vati 500mg BD orally after meal with Karanja Tail local application for 30 days and follow up on 0th, 16th and 31th day.This study is conducted as PG course at single centre.The primary outcome is decrease in itching, pain, dryness of lesion and decrease in size of 1 or 2 large lesion

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
33
Inclusion Criteria

The patient will be diagnosed on the basis of Symptoms of Vicharchika(Eczema) given in Sushruta Samhita a) Mandala (patches) b) Atikandu (severe itching) c) Ruja (pain) d) Rukshata (dryness) Patients who are co-operative and ready to give written consent Duration of symptoms is 1 year.

Exclusion Criteria

Patients having skin disorder other than eczema Eczema with systemic illness like severe DM, IHD Complicated or steroid dependent Eczema.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in itching, pain, dryness of lesion and decrease in size of 1 or 2 large lesions30days
Secondary Outcome Measures
NameTimeMethod
Nishadi Ghana Vati orally with Karanja Tail local application is more effective than Arogyavardhini Vati orally with Karanja Tail local applicationIn 31 days

Trial Locations

Locations (1)

Government Ayurved Hospital, Vazirabad, Nanded

🇮🇳

Nanded, MAHARASHTRA, India

Government Ayurved Hospital, Vazirabad, Nanded
🇮🇳Nanded, MAHARASHTRA, India
Manisa Singh
Principal investigator
8339065877
manisasingh688@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.